MedTrace Logo

Early Detection of Developmental Abnormalities of Preterm Infants at 5 Years of Age

NCT07391527 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 210

Last updated 2026-02-06

No results posted yet for this study

Summary

The project is a national, prospective, multicenter, interventional pilot project focused on the follow up of 5 year old children that were born prematurely.

The primary aim of the project is to prepare, test, and develop a proposal for a national methodology for the care of children born prematurely. This will minimize the negative impacts on the overall development of the child and the family of the prematurely born children.

Conditions

  • 5 Year Old Children Born Prematurely

Interventions

OTHER

Pediatric check-up

Eligible children are invited to undergo a comprehensive pediatric evaluation, including vision screening (Plusoptix) and speech and language tests (TEPO - sentence comprehension, TEPRO - vocabulary production). Subsequently, children are referred for psychological (IDS-P), motor (MABC-2), and pulmonary (spirometry) assessments. If any deviations are identified, the child is referred to appropriate specialists (e.g., rehabilitation physician, speech therapist, psychiatrist, ophthalmologist).

Sponsors & Collaborators

  • České Budějovice Hospital

    collaborator OTHER

  • General University Hospital, Prague

    collaborator OTHER

  • Hospital Havlickuv Brod

    collaborator UNKNOWN

  • County Hospital Liberec, Liberec

    collaborator UNKNOWN

  • Institute of Health Information and Statistics of the Czech Republic

    lead OTHER_GOV

Principal Investigators

  • Daniela Marková, M.D. · General Hospital University in Prague

  • Richard Plavka, prof. · General Hospital University in Prague

Study Design

Allocation
NA
Purpose
SCREENING
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
5 Years
Max Age
5 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-09-23
Primary Completion
2026-11-30
Completion
2027-02-28

Countries

  • Czechia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07391527 on ClinicalTrials.gov